Lee Jeong Hoo, Szpak Veronica, Vercollone Lisa W, Chai Peter R, Goldfine Charlotte E, Maddams Samuel, Suzuki Joji
Department of Psychiatry, Brigham and Women's Faulkner Hospital, Boston, MA, United States.
Harvard Medical School, Boston, MA, United States.
Front Psychiatry. 2025 Jun 13;16:1567617. doi: 10.3389/fpsyt.2025.1567617. eCollection 2025.
This study aimed to determine if phosphatidylethanol (PEth) levels are associated with alcohol withdrawal severity among individuals seeking inpatient withdrawal management.
A prospective study enrolled individuals undergoing alcohol withdrawal treatment at a ASAM level 4 inpatient unit. Primary outcome was the association between serum PEth levels with alcohol withdrawal medication requirements in diazepam equivalent (mg). Secondary objectives examined associations between PEth levels, Clinical Institute Withdrawal Assessment for Alcohol (CIWA) scores, drinking history, Alcohol Use Disorders Identification Test (AUDIT), and Prediction of Alcohol Withdrawal Severity Scale (PAWSS) scores.
Thirty participants (mean age 48.7 years, SD 11.7; 67.7% white) reported average daily alcohol consumption of 14.2 drinks (SD 11.4, range 1.2-47.6) and percent heavy drinking days of 72% (SD 31.9, range 13.3-100). Nine (29%) reported history of withdrawal seizures and seven (22.6%) reported history of delirium tremens. Admission PEth (PO, ng/mL) levels (mean 934.9, SD 546.6; range 42 - 2000-) did not significantly associate with total medication requirements (r=0.05, p=0.78) or CIWA scores (r=0.09 to -0.14, p>0.05). PEth levels showed no significant correlations with AUDIT (r=0.17, p=0.35) or PAWSS scores (r=0.13, p=0.50). However, significant correlations were found between PEth levels and average drinks per day (r=0.54, p=0.002), as well as with the percentage of heavy drinking days (r=0.54, p=0.002).
Consistent with prior reports, PEth levels appear to correlate with patients' alcohol consumption including heavy drinking, but our results did not find that PEth levels predict alcohol withdrawal severity among heavy drinkers seeking inpatient withdrawal management. Further research is warranted to better understand the utility of PEth testing.
本研究旨在确定在寻求住院戒酒管理的个体中,磷脂酰乙醇(PEth)水平是否与酒精戒断严重程度相关。
一项前瞻性研究纳入了在一个美国成瘾医学协会(ASAM)4级住院单元接受酒精戒断治疗的个体。主要结局是血清PEth水平与以地西泮当量(mg)计算的酒精戒断药物需求量之间的关联。次要目标是研究PEth水平、酒精临床戒断评估量表(CIWA)评分、饮酒史、酒精使用障碍识别测试(AUDIT)以及酒精戒断严重程度预测量表(PAWSS)评分之间的关联。
30名参与者(平均年龄48.7岁,标准差11.7;67.7%为白人)报告平均每日饮酒量为14.2杯(标准差11.4,范围1.2 - 47.6),重度饮酒天数百分比为72%(标准差31.9,范围13.3 - 100)。9人(29%)报告有戒断性癫痫病史,7人(22.6%)报告有震颤谵妄病史。入院时的PEth(PO,ng/mL)水平(平均934.9,标准差546.6;范围42 - 2000 -)与总药物需求量(r = 0.05,p = 0.78)或CIWA评分(r = 0.09至 -0.14,p>0.05)无显著关联。PEth水平与AUDIT(r = 0.17,p = 0.35)或PAWSS评分(r = 0.13,p = 0.50)无显著相关性。然而,发现PEth水平与每日平均饮酒量(r = 0.54,p = 0.002)以及重度饮酒天数百分比(r = 0.54,p = 0.002)之间存在显著相关性。
与先前报告一致,PEth水平似乎与患者的酒精摄入量(包括重度饮酒)相关,但我们的结果并未发现PEth水平可预测寻求住院戒酒管理的重度饮酒者的酒精戒断严重程度。有必要进行进一步研究以更好地了解PEth检测的效用。